Related Experiment Video
Updated: Oct 23, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Population-based assessment of risks for severe COVID-19 disease outcomes
Ousseny Zerbo1, Ned Lewis1, Bruce Fireman1
1Vaccine Study Center, Kaiser Permanente Northern California, Oakland, California, USA.
Insights
Severe COVID-19 disproportionately affected older adults and minority groups. Alzheimer's and Parkinson's diseases significantly increased hospitalization and death risks.
Area of Science:
- Epidemiology
- Public Health
- Geriatric Medicine
Background:
- COVID-19 has caused significant morbidity and mortality globally.
- Understanding risk factors for severe COVID-19 outcomes is crucial for public health interventions.
- Demographic factors and pre-existing conditions are suspected to influence COVID-19 severity.
Purpose of the Study:
- To investigate associations between demographic factors and comorbidities with severe COVID-19 outcomes.
- To identify specific risk factors for hospitalization, intensive care unit (ICU) admission, and death due to COVID-19.
Main Methods:
- Retrospective cohort study analyzing data from approximately 4.6 million members of Kaiser Permanente Northern California.
- Data collected up to July 23, 2021.
- Statistical analysis to determine hazard ratios (aHR) and confidence intervals (CI) for associations.
Main Results:
- Age was strongly associated with increased risk of hospitalization, ICU admission, and death.
- Black persons and individuals of Hispanic ethnicity exhibited a higher risk of death compared to White individuals.
- Alzheimer's disease showed the highest risk for hospitalization (aHR 3.19) and death (aHR 4.04). Parkinson's disease was associated with the second highest risk of death (aHR 2.07).
Conclusions:
- Severe COVID-19 outcomes are significantly influenced by age and ethnicity.
- Certain neurodegenerative diseases, particularly Alzheimer's and Parkinson's, are potent risk factors for severe COVID-19.
- Findings highlight the need for targeted preventive strategies for vulnerable populations and individuals with specific comorbidities.
Abstract:
Among approximately 4.6 million members of Kaiser Permanente Northern California, we examined associations of severe COVID-19 with demographic factors and comorbidities. As of July 23, 2021, 16 182 had been hospitalized, 2416 admitted to an ICU, and 1525 died due to COVID-19. Age was strongly associated with hospitalization, ICU admission, and death. Black persons and Hispanic ethnicity had higher risk of death compared with Whites. Among the comorbidities examined, Alzheimer's disease was associated with the highest risk for hospitalization (aHR 3.19, CI: 2.88-3.52) and death (aHR 4.04, CI: 3.32-4.91). Parkinson's disease had the second highest risk of death (aHR = 2.07, CI: 1.50-2.87).
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Relative Risk
Pneumonia III: Complications and Assessment
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Steps in Outbreak Investigation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History

